Description: MGC Pharmaceuticals Limited, formerly Erin Resources Limited, is a medical and cosmetics cannabis company. The Company is engaged in the creating cannabidiol (CBD) and medical cannabis business that focuses on the CBD market in Europe. CBD is used for the treatment of a range of skin and health conditions, including acne, psoriasis, eczema and dry skin. The Company's business model involves in growing cannabis sativa plants from high CBD yielding seeds and extracting CBD resin from the plants grown. It sells the CBD resins as a wholesale product to cosmetic and therapeutic product manufacturers. The CBD is also used to produce the Company's line of cosmetic products in Slovenia under the Ananda Cosmetics Joint Venture. It grows, harvests, dries out, extracts and sells cannabis sativa crop to enterprise customers in bulk, individual consumers in delivery devices or other products. The Company subsidiaries include MGC Pharma (UK) Ltd and MGC Pharmaceuticals d.o.o.
Home Page: mgcpharma.com.au
MXC Technical Analysis
1202 Hay Street
West Perth,
WA
6005
Australia
Phone:
61 8 6382 3390
Officers
| Name | Title |
|---|---|
| Mr. Roby Reuven Zomer | Co-Founder, CEO, MD & Exec. Director |
| Ms. Angela-Marie Graham | Group Chief Financial Officer |
| Ms. Yifat Steuer | Deputy CEO & COO |
| Mr. Amir Polak | Chief Technology Officer |
| Ms. Nicole Ann Godresse | Global Chief Sales Officer |
| Ms. Sabina Suljakovic | Head of the Quality Assurance Department |
| Dr. Nadya Lisovoder | Chief Medical Officer |
| Ms. Sasha Friedman | Deputy CEO |
| Yair Tal | Chief Information Security Officer |
| Mr. Robert Clements | Chief Commercial Officer |
Exchange: AU
Country: AU
Currency: Australian Dollar (A$)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 14.9031 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 5.8913 |
| Price-to-Sales TTM: | 7.8732 |
| IPO Date: | 2006-12-15 |
| Fiscal Year End: | June |
| Full Time Employees: | 0 |